Product Information
BUPIVACAINE 0.25% VIAL is a generic product labeled by Xellia Pharmaceuticals USA LLC, priced at $0.0479 per ML under NDC 70594011601. Its NADAC has been published 36 times since Oct 22, 2025.
Strength
2.5 mg/mL
Manufacturer
Xellia Pharmaceuticals USA LLCNDC
70594011601
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
PERINEURAL
Last Updated
5/20/2026
Active Ingredients
BUPIVACAINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA091503On Market Since
8/1/2023
Pharmacological Classes
Price Statistics
The NADAC for BUPIVACAINE 0.25% VIAL has been published 36 times since Oct 22, 2025, and over the history we have for it it has risen 3.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0479 per ML |
|---|---|
| All-time high | $0.0479 (Jun 24, 2026) |
| All-time low | $0.0453 (Nov 19, 2025) |
| 52-week high | $0.0479 |
| 52-week low | $0.0453 |
| Median price | $0.0476 |
| Average price | $0.0470 |
| Largest weekly change | +2.6% (Feb 18, 2026) |
| Weeks tracked | 36 |
| Tracking since | Oct 22, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Bupivacaine Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of BUPIVACAINE 0.25% VIAL?
The current National Average Drug Acquisition Cost (NADAC) for BUPIVACAINE 0.25% VIAL, manufactured by Xellia Pharmaceuticals USA LLC, is $0.0479 per ML (NDC 70594011601), effective Jun 24, 2026.
How has the price of BUPIVACAINE 0.25% VIAL changed over time?
Over the history we have for it, the NADAC for BUPIVACAINE 0.25% VIAL has risen 3.4%. It has been tracked across 36 weekly CMS publications since Oct 22, 2025.
What are the highest and lowest recorded NADAC prices for BUPIVACAINE 0.25% VIAL?
Since Oct 22, 2025, the NADAC for BUPIVACAINE 0.25% VIAL has ranged from a low of $0.0453 (Nov 19, 2025) to a high of $0.0479 (Jun 24, 2026), with a median of $0.0476 per ML.
Are there cheaper alternatives to BUPIVACAINE 0.25% VIAL?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of BUPIVACAINE 0.25% VIAL, so no direct lower-cost alternative is listed.
Who manufactures BUPIVACAINE 0.25% VIAL?
BUPIVACAINE 0.25% VIAL (NDC 70594011601) is labeled by Xellia Pharmaceuticals USA LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification